In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women.
Lactobacilli have been shown to inhibit in vitro growth of many pathogens and have been used as probiotics to treat a broad range of gastrointestinal and/or vaginal disorders. We sought to determine the in vitro inhibitory potential of lactobacilli of vaginal origin to some bacteria associated with bacterial vaginosis (BV), to characterize the inhibitory substances produced by these lactobacilli and to assess H2O2 production. Vaginal specimens were obtained by swabbing the lateral vaginal walls from 107 women two months following BV treatment. One hundred and fifty eight Lactobacillus spp. were isolated in 82 of the 107 women. Lactobacillus jensenii was the predominant strain isolated among these women (29/158; 18.4%). Among 158 culture supernatants tested for antibacterial activity against BV-associated bacteria, none inhibited the growth of Bacteroides fragilis while 23% (37/158), 28% (45/158) and 29% (46/158) inhibited the growth of Prevotella bivia, Gardnerella vaginalis and Mobiluncus spp. respectively. The lactobacilli produced supernatants with a pH range between 2.62 and 6.71; the highly acidic (pH 2-3.99) supernatants were more inhibitory to the indicator strains. There was significant reduction in the mean zones of inhibition following chemical and physical treatment of the supernatants (p = 0.0025). Acid, bacteriocins and H2O2 demonstrated potential for antagonism of the bacterial pathogens. These substances may augment each other rather that each working independently on the pathogens.
Matu
Martin N
MN
Department of Biochemistry and Biotechnology, Kenyatta University, P.O. Box 43844, 00100 Nairobi, Kenya. martinmatu@gmail.com
Orinda
George O
GO
Njagi
Eliud N M
EN
Cohen
Craig R
CR
Bukusi
Elizabeth A
EA
D000143:Acids / Q000378:metabolism / Q000494:pharmacology; D000898:Antibiosis; D001430:Bacteriocins / Q000378:metabolism / Q000494:pharmacology; D017077:Culture Media, Conditioned / Q000494:pharmacology; D005260:Female; D006194:Gardnerella vaginalis / Q000187:drug effects / Q000254:growth & development*; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism / Q000494:pharmacology; D007630:Kenya; D007778:Lactobacillus / Q000378:metabolism*; D017904:Mobiluncus / Q000187:drug effects / Q000254:growth & development*; D018720:Prevotella / Q000187:drug effects / Q000254:growth & development*; D014621:Vagina / Q000382:microbiology*; D016585:Vaginosis, Bacterial / Q000382:microbiology*
D000143:Acids; D001430:Bacteriocins; D017077:Culture Media, Conditioned; D006861:Hydrogen Peroxide